| 1 | [SID50107733] | Active | Potency | 8.9125 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 2 | [SID50107733] | Active | Potency | 8.9125 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 3 | [SID50107733] | Active | Potency | 8.9125 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 4 | [SID50107733] | Active | Potency | 8.9125 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 5 | [SID50107733] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 6 | [SID50107733] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 7 | [SID26749851] | Active | Potency | 17.7828 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 8 | [SID26749851] | Active | Potency | 17.7828 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 9 | [SID26749851] | Active | Potency | 17.7828 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 10 | [SID26749851] | Active | Potency | 17.7828 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 11 | [SID26749851] | Active | Potency | 50.1187 | Inhibitors of USP1/UAF1: Pilot qHTS [AID504865, Type: confirmatory] | USP1 protein [Homo sapiens] [gi:118600387] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | Inhibitors of USP1/UAF1: Pilot qHTS | | AID | 504865 | | BioAssay type | confirmatory | | Target | USP1 protein [Homo sapiens] [gi:118600387] | | PubMed | | | Data Table |  |
|
| 12 | [SID50107733] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 50107733 | | CID | 6755 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 13 | [SID103222862] | Unspecified | IC50 | 100 | Inhibitory activity against HIV-1 integrase [AID93531, Type: Literature] | Integrase [gi:82312013] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Inhibitory activity against HIV-1 integrase | | AID | 93531 | | BioAssay type | Literature | | Target | Integrase [gi:82312013] | | PubMed | 8691444 | | Data Table |  |
|
| 14 | [SID103222862] | Unspecified | IC50 | 100 | Inhibitory activity against HIV-1 integrase [AID93543, Type: Literature] | Integrase [gi:82312013] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Inhibitory activity against HIV-1 integrase | | AID | 93543 | | BioAssay type | Literature | | Target | Integrase [gi:82312013] | | PubMed | 8691444 | | Data Table |  |
|
| 15 | [SID103222862] | Unspecified | IC50 | 100 | Inhibitory activity against HIV-1 protease [AID162196, Type: Literature] | Pol polyprotein [gi:75593047] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Inhibitory activity against HIV-1 protease | | AID | 162196 | | BioAssay type | Literature | | Target | Pol polyprotein [gi:75593047] | | PubMed | 8691444 | | Data Table |  |
|
| 16 | [SID103222862] | Unspecified | IC50 | 100 | In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain) [AID152094, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | In vitro antimalarial activity against human malaria parasite, P falciparum (Vietnam Smith strain) | | AID | 152094 | | BioAssay type | Literature | | Target | | | PubMed | 2033589 | | Data Table |  |
|
| 17 | [SID103222862] | Unspecified | IC50 | 150 | Inhibitory activity against HRV 3Cpro using HPLC assay [AID163631, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 150 [uM] | | BioAssay | Inhibitory activity against HRV 3Cpro using HPLC assay | | AID | 163631 | | BioAssay type | Literature | | Target | | | PubMed | 11720861 | | Data Table |  |
|
| 18 | [SID103544392] | Unspecified | IC50 | 675 | Inhibition of purified human recombinant IDO [AID326467, Type: Literature] | Indoleamine 2,3-dioxygenase 1 [gi:123948] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 675 [uM] | | BioAssay | Inhibition of purified human recombinant IDO | | AID | 326467 | | BioAssay type | Literature | | Target | Indoleamine 2,3-dioxygenase 1 [gi:123948] | | PubMed | 18318466 | | Data Table |  |
|
| 19 | [SID103544392] | Unspecified | IC50 | 2500 | Trypanocidal activity against bloodstream form of Trypanosoma cruzi Y isolated from albino mouse blood after 24 hrs by neubauer chamber analysis [AID660266, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | IC50 | 2500 [uM] | | BioAssay | Trypanocidal activity against bloodstream form of Trypanosoma cruzi Y isolated from albino mouse blood after 24 hrs by neubauer chamber analysis | | AID | 660266 | | BioAssay type | Literature | | Target | | | PubMed | 22483633 | | Data Table |  |
|
| 20 | [SID103544392] | Unspecified | | | Inhibition of papain at 1.3 mM after 20 mins [AID308236, Type: Literature] | Papain [gi:129614] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of papain at 1.3 mM after 20 mins | | AID | 308236 | | BioAssay type | Literature | | Target | Papain [gi:129614] | | PubMed | 17532221 | | Data Table |  |
|
| 21 | [SID103544392] | Unspecified | | | Inhibition of mushroom tyrosinase at 1 mM after 10 mins [AID566699, Type: Literature] | Polyphenol oxidase 2 [gi:6686057] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of mushroom tyrosinase at 1 mM after 10 mins | | AID | 566699 | | BioAssay type | Literature | | Target | Polyphenol oxidase 2 [gi:6686057] | | PubMed | 21189019 | | Data Table |  |
|
| 22 | [SID103544392] | Unspecified | | | Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay [AID566700, Type: Literature] | Arachidonate 5-lipoxygenase [gi:126407] |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay | | AID | 566700 | | BioAssay type | Literature | | Target | Arachidonate 5-lipoxygenase [gi:126407] | | PubMed | 21189019 | | Data Table |  |
|
| 23 | [SID103544392] | Unspecified | | | Antiinflammatory activity in CD1 mouse assessed as inhibition of croton oil-induced ear oedema at 0.3 umol/cm^2 after 6 hrs [AID309363, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antiinflammatory activity in CD1 mouse assessed as inhibition of croton oil-induced ear oedema at 0.3 umol/cm^2 after 6 hrs | | AID | 309363 | | BioAssay type | Literature | | Target | | | PubMed | 17768049 | | Data Table |  |
|
| 24 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 250 ug/ml after 4 hrs by XTT assay relative to control [AID349291, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 250 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349291 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 25 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 125 ug/ml after 4 hrs by XTT assay relative to control [AID349292, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 125 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349292 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 26 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 62.5 ug/ml after 4 hrs by XTT assay relative to control [AID349293, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 62.5 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349293 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 27 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 31.2 ug/ml after 4 hrs by XTT assay relative to control [AID349294, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 31.2 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349294 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 28 | [SID103544392] | Unspecified | | | Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation at 31.3 ug/ml after 48 hrs [AID349300, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation at 31.3 ug/ml after 48 hrs | | AID | 349300 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 29 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 15.6 ug/ml after 4 hrs by XTT assay relative to control [AID349295, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 15.6 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349295 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 30 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 7.8 ug/ml after 4 hrs by XTT assay relative to control [AID349296, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 7.8 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349296 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 31 | [SID103544392] | Unspecified | | | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 3.9 ug/ml after 4 hrs by XTT assay relative to control [AID349297, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 assessed as bacterial growth at 3.9 ug/ml after 4 hrs by XTT assay relative to control | | AID | 349297 | | BioAssay type | Literature | | Target | | | PubMed | 18093697 | | Data Table |  |
|
| 32 | [SID103222862] | Unspecified | | | Partition coefficient (logP) [AID23482, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 23482 | | BioAssay type | Literature | | Target | | | PubMed | 6834390 | | Data Table |  |
|
| 33 | [SID103222862] | Unspecified | | | Effective dose that would give a 25% increase in the survival time against the ascitic sarcoma 180 in mice [AID39233, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Effective dose that would give a 25% increase in the survival time against the ascitic sarcoma 180 in mice | | AID | 39233 | | BioAssay type | Literature | | Target | | | PubMed | 6834390 | | Data Table |  |
|
| 34 | [SID103222862] | Unspecified | | | Solubility in water was determined [AID21140, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Solubility in water was determined | | AID | 21140 | | BioAssay type | Literature | | Target | | | PubMed | 6834390 | | Data Table |  |
|
| 35 | [SID103222862] | Unspecified | | | Tested for its ability to eliminate the infective trypomastigote form of Trypanosoma cruzi, Y strain present in blood of infected mice at the dose of 0.29 mM [AID115276, Type: other] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Tested for its ability to eliminate the infective trypomastigote form of Trypanosoma cruzi, Y strain present in blood of infected mice at the dose of 0.29 mM | | AID | 115276 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID103222862] | Unspecified | | | Tested for acute toxicity which is the single dose given intraperitoneally that will kill one-half of the mice within 5 days [AID117228, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Tested for acute toxicity which is the single dose given intraperitoneally that will kill one-half of the mice within 5 days | | AID | 117228 | | BioAssay type | Literature | | Target | | | PubMed | 6834390 | | Data Table |  |
|
| 37 | [SID103222862] | Unspecified | | | Maximum survival by an optimum dose at 25 mg/kg in treated to that of untreated mice [AID117488, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103222862 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Maximum survival by an optimum dose at 25 mg/kg in treated to that of untreated mice | | AID | 117488 | | BioAssay type | Literature | | Target | | | PubMed | 6834390 | | Data Table |  |
|
| 38 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP1 at 1 mM after 30 mins [AID566702, Type: Literature] | Interstitial collagenase [gi:116852] |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP1 at 1 mM after 30 mins | | AID | 566702 | | BioAssay type | Literature | | Target | Interstitial collagenase [gi:116852] | | PubMed | 21189019 | | Data Table |  |
|
| 39 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP2 at 1 mM after 30 mins [AID566703, Type: Literature] | 72 kDa type IV collagenase [gi:116856] |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP2 at 1 mM after 30 mins | | AID | 566703 | | BioAssay type | Literature | | Target | 72 kDa type IV collagenase [gi:116856] | | PubMed | 21189019 | | Data Table |  |
|
| 40 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP2 at 1 mM after 30 mins [AID566703, Type: Literature] | 72 kDa type IV collagenase [gi:116856] |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP2 at 1 mM after 30 mins | | AID | 566703 | | BioAssay type | Literature | | Target | 72 kDa type IV collagenase [gi:116856] | | PubMed | 21189019 | | Data Table |  |
|
| 41 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP2 at 1 mM after 30 mins [AID566703, Type: Literature] | 72 kDa type IV collagenase [gi:116856] |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP2 at 1 mM after 30 mins | | AID | 566703 | | BioAssay type | Literature | | Target | 72 kDa type IV collagenase [gi:116856] | | PubMed | 21189019 | | Data Table |  |
|
| 42 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP3 at 1 mM after 30 mins [AID566704, Type: Literature] | Stromelysin-1 [gi:116857] |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP3 at 1 mM after 30 mins | | AID | 566704 | | BioAssay type | Literature | | Target | Stromelysin-1 [gi:116857] | | PubMed | 21189019 | | Data Table |  |
|
| 43 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP3 at 1 mM after 30 mins [AID566704, Type: Literature] | Stromelysin-1 [gi:116857] |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP3 at 1 mM after 30 mins | | AID | 566704 | | BioAssay type | Literature | | Target | Stromelysin-1 [gi:116857] | | PubMed | 21189019 | | Data Table |  |
|
| 44 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP8 at 1 mM after 30 mins [AID566705, Type: Literature] | Neutrophil collagenase [gi:116862] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP8 at 1 mM after 30 mins | | AID | 566705 | | BioAssay type | Literature | | Target | Neutrophil collagenase [gi:116862] | | PubMed | 21189019 | | Data Table |  |
|
| 45 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP8 at 1 mM after 30 mins [AID566705, Type: Literature] | Neutrophil collagenase [gi:116862] |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP8 at 1 mM after 30 mins | | AID | 566705 | | BioAssay type | Literature | | Target | Neutrophil collagenase [gi:116862] | | PubMed | 21189019 | | Data Table |  |
|
| 46 | [SID103544392] | Unspecified | | | Inhibition of human recombinant MMP9 at 1 mM after 30 mins [AID566706, Type: Literature] | Matrix metalloproteinase-9 [gi:269849668] |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant MMP9 at 1 mM after 30 mins | | AID | 566706 | | BioAssay type | Literature | | Target | Matrix metalloproteinase-9 [gi:269849668] | | PubMed | 21189019 | | Data Table |  |
|
| 47 | [SID103544392] | Unspecified | | | Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay [AID566701, Type: Literature] | Lethal factor [gi:50402185] |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103544392 | | CID | 6755 | | Outcome | Unspecified | | BioAssay | Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay | | AID | 566701 | | BioAssay type | Literature | | Target | Lethal factor [gi:50402185] | | PubMed | 21189019 | | Data Table |  |
|
| 48 | [SID26749851] | Inactive | Potency | 0.0316 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Inactive | | Potency | 0.0316 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 49 | [SID26749851] | Inactive | Potency | 0.0316 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Inactive | | Potency | 0.0316 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 50 | [SID26749851] | Inactive | Potency | 0.0316 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26749851 | | CID | 6755 | | Outcome | Inactive | | Potency | 0.0316 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|